Catalyst Wire Dossier Catalyst Wire Dossier

YUTREPIA

treprostinil · Liquidia Technologies, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YUTREPIA, covering 2025-05-23 to 2025-05-23. Get the full timeline:

Most recent: FDA Approved: YUTREPIA — Original Application (Liquidia Technologies, Inc.)

See pricing